| scholarly article | Q13442814 |
| P50 | author | Rodrigo F da Silva | Q50558813 |
| Sophie F. Derchain | Q50558827 | ||
| Fernando Guimarães | Q60634851 | ||
| Silke Paust | Q77404691 | ||
| Rodrigo Menezes Jales | Q83732265 | ||
| P2093 | author name string | Daniela Maira Cardozo | |
| Adriana Yoshida | |||
| P2860 | cites work | The immune system in the pathogenesis of ovarian cancer | Q37613407 |
| Ovarian cancer creates a suppressive microenvironment to escape immune elimination | Q37689997 | ||
| B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors | Q37923837 | ||
| Targeting cancer-derived adenosine: new therapeutic approaches | Q38230818 | ||
| Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. | Q39531156 | ||
| Natural killer cells in human solid tumors | Q40110364 | ||
| CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer | Q40327394 | ||
| Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells | Q40424164 | ||
| TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway | Q40788629 | ||
| Malignant ascites | Q41000476 | ||
| Up-regulation of DNAM-1 and NKp30, associated with improvement of NK cells activation after long-term culture of mononuclear cells from patients with ovarian neoplasia | Q45865576 | ||
| Clinical significance of ascites in epithelial ovarian cancer. | Q45945444 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Targeted immune therapy of ovarian cancer | Q28082828 | ||
| The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells | Q28249199 | ||
| Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells | Q28260343 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| IgG Fc receptors | Q29615378 | ||
| CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
| MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress | Q33713506 | ||
| Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells | Q33901387 | ||
| „Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell | Q33906475 | ||
| Natural killer cells, viruses and cancer | Q34119645 | ||
| Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors | Q34442318 | ||
| Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. | Q34515741 | ||
| Human T regulatory cells can use the perforin pathway to cause autologous target cell death | Q34551876 | ||
| Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization | Q34557233 | ||
| Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3. | Q35195777 | ||
| Unravelling natural killer cell function: triggering and inhibitory human NK receptors | Q35611389 | ||
| B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape | Q35798978 | ||
| Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. | Q35818203 | ||
| Activated CD4+CD25+ T cells selectively kill B lymphocytes | Q35848308 | ||
| Mechanisms of suppression by suppressor T cells | Q36078047 | ||
| B7-H6 expression correlates with cancer progression and patient's survival in human ovarian cancer | Q36095328 | ||
| Ovarian cancer metastasis: integrating insights from disparate model organisms | Q36111930 | ||
| Regulatory T cells in ovarian cancer: biology and therapeutic potential | Q36321305 | ||
| CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner | Q36403637 | ||
| Tumor and viral recognition by natural killer cells receptors | Q36558852 | ||
| Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells | Q36916476 | ||
| Negative signaling by inhibitory receptors: the NK cell paradigm | Q36983705 | ||
| Tumor necrosis factor and cancer, buddies or foes? | Q37073092 | ||
| CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance | Q37106789 | ||
| Functional analysis of human NK cells by flow cytometry. | Q37143310 | ||
| The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells | Q37186494 | ||
| Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research | Q37196532 | ||
| Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients | Q50769683 | ||
| NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma | Q53257187 | ||
| Isolation and characterization of human natural killer cell subsets | Q53481399 | ||
| Social support, psychological distress, and natural killer cell activity in ovarian cancer | Q53655521 | ||
| Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma | Q56904280 | ||
| Identification of FOXP3-negative regulatory T-like (CD4+CD25+CD127low) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome | Q56963542 | ||
| DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells | Q57226771 | ||
| Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherap | Q57904741 | ||
| NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells | Q61953868 | ||
| Recombinant IL-2-activated NK cells mediate LAK activity against ovarian cancer | Q68096412 | ||
| Natural immunity against ovarian tumors | Q68810929 | ||
| Natural killer cell activity in patients with ovarian tumors and uterine myomas | Q72498723 | ||
| Clinical impact of tumor-infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis | Q85639677 | ||
| Differences in FOXP3 and CD127 expression in Treg-like cells in patients with IPEX syndrome | Q87671459 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P577 | publication date | 2017-05-17 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients | |
| P478 | volume | 18 |
| Q47121377 | Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells |
| Q92800249 | NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune Response |
| Q58582595 | Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients |
| Q47773956 | Revisiting ovarian cancer microenvironment: a friend or a foe? |
| Q64256318 | Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer |
| Q90189356 | Three-Dimensional Cell Culture Based on Magnetic Fields to Assemble Low-Grade Ovarian Carcinoma Cell Aggregates Containing Lymphocytes |
Search more.